Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic.
Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic.
复制标题
DOI:
10.1021/acs.jmedchem.1c02034
复制
发表时间:
2022-05-12
影响因子:
7.3
通讯作者:
Sintim, Herman O.
中科院分区:
文献类型:
--
作者:
Naclerio, George A.;Abutaleb, Nader S.;Onyedibe, Kenneth, I;Karanja, Caroline;Eldesouky, Hassan E.;Liang, Hsin-Wen;Dieterly, Alexandra;Aryal, Uma K.;Lyle, Tiffany;Seleem, Mohamed N.;Sintim, Herman O.
Methicillin-resistant Staphylococcus aureus (MRSA) infections are still difficult to treat, despite the availability of many FDA-approved antibiotics. Thus, new compound scaffolds are still needed to treat MRSA. The oxadiazole-containing compound, HSGN-94, has been shown to reduce lipoteichoic acid (LTA) in S. aureus, but the mechanism that accounts for LTA biosynthesis inhibition remains uncharacterized. Here, we report the elucidation of the mechanism by which HSGN-94 inhibits LTA biosynthesis via utilization of global proteomics, activity-based protein profiling, and lipid analysis via multiple reaction monitoring (MRM). Our data suggest that HSGN-94 inhibits LTA biosynthesis via direct binding to PgcA and downregulation of PgsA. We further show that HSGN-94 reduces the MRSA load in skin infection (mouse) and decreases pro-inflammatory cytokines in MRSA infected wounds. Collectively, HSGN-94 merits further consideration as a potential drug for staphylococcal infections.
登录
查看更多内容
影响因子:
2.7
作者:
Abutaleb NS;Elhassanny AEM;Flaherty DP;Seleem MN
通讯作者:
Seleem MN
影响因子:
3.7
作者:
Montgomery CP;Daniels MD;Zhao F;Spellberg B;Chong AS;Daum RS
通讯作者:
Daum RS
影响因子:
6.5
作者:
Brauweiler, Anne M.;Goleva, Elena;Leung, Donald Y. M.
通讯作者:
Leung, Donald Y. M.
影响因子:
4.4
作者:
Chaudhuri RR;Allen AG;Owen PJ;Shalom G;Stone K;Harrison M;Burgis TA;Lockyer M;Garcia-Lara J;Foster SJ;Pleasance SJ;Peters SE;Maskell DJ;Charles IG
通讯作者:
Charles IG
影响因子:
4.4
作者:
Cox, Juergen;Neuhauser, Nadin;Mann, Matthias
通讯作者:
Mann, Matthias